N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-methoxyethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(1,2,4-triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine;methane;N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine

C120H110F14N40O6S — CID 160605176

About N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-methoxyethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(1,2,4-triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine;methane;N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine

N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-methoxyethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(1,2,4-triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine;methane;N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine (PubChem CID 160605176) has the molecular formula C120H110F14N40O6S and a molecular weight of 2506.51 g/mol. Its IUPAC name is N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-methoxyethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(1,2,4-triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine;methane;N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine.

Molecular Properties

• Compound Name: N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-methoxyethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(1,2,4-triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine;methane;N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine
• PubChem CID: 160605176
• Molecular Formula: C120H110F14N40O6S
• Molecular Weight: 2506.51 g/mol
• Exact Mass: 2504.90
• IUPAC Name: N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-methoxyethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(1,2,4-triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine;methane;N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine
• SMILES: C.C.C.C.C.COCCOc1cnc2c(NCc3nnc4ccc(-c5cc(F)cc(F)c5)nn34)ccnc2c1.Cc1cc(-c2ccc3nnc(CNc4ccnc5cc(OCC(F)(F)F)cnc45)n3n2)sn1.Fc1cc(F)cc(-c2ccc3nnc(CNc4ccnc5cc(OCC(F)(F)F)cnc45)n3n2)c1.Fc1cc(F)cc(-c2ccc3nnc(CNc4ccnc5cc(OCCN6CCCC6)cnc45)n3n2)c1.Fc1cc(F)cc(-c2ccc3nnc(CNc4ccnc5cc(OCCn6cncn6)cnc45)n3n2)c1
• InChI: InChI=1S/C26H24F2N8O.C24H18F2N10O.C23H19F2N7O2.C22H14F5N7O.C20H15F3N8OS.5CH4/c27-18-11-17(12-19(28)13-18)21-3-4-24-32-33-25(36(24)34-21)16-30-22-5-6-29-23-14-20(15-31-26(22)23)37-10-9-35-7-1-2-8-35;25-16-7-15(8-17(26)9-16)19-1-2-22-32-33-23(36(22)34-19)12-29-20-3-4-28-21-10-18(11-30-24(20)21)37-6-5-35-14-27-13-31-35;1-33-6-7-34-17-11-20-23(28-12-17)19(4-5-26-20)27-13-22-30-29-21-3-2-18(31-32(21)22)14-8-15(24)10-16(25)9-14;23-13-5-12(6-14(24)7-13)16-1-2-19-31-32-20(34(19)33-16)10-29-17-3-4-28-18-8-15(9-30-21(17)18)35-11-22(25,26)27;1-11-6-16(33-30-11)13-2-3-17-27-28-18(31(17)29-13)9-25-14-4-5-24-15-7-12(8-26-19(14)15)32-10-20(21,22)23;;;;;/h3-6,11-15H,1-2,7-10,16H2,(H,29,30);1-4,7-11,13-14H,5-6,12H2,(H,28,29);2-5,8-12H,6-7,13H2,1H3,(H,26,27);1-9H,10-11H2,(H,28,29);2-8H,9-10H2,1H3,(H,24,25);5*1H4
• InChIKey: RETXUGRHRWJPJI-UHFFFAOYSA-N
• XLogP: 22.84
• TPSA: 506.67 Ų
• H-Bond Donors: 5
• H-Bond Acceptors: 47
• Rotatable Bonds: 36
• Heavy Atoms: 181
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2506.51
LogP ≤ 5	22.84
H-Bond Donors ≤ 5	5
H-Bond Acceptors ≤ 10	47

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-methoxyethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(1,2,4-triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine;methane;N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine?

The IUPAC name of N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-methoxyethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(1,2,4-triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine;methane;N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine (CID 160605176) is N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-methoxyethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(1,2,4-triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine;methane;N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine.

What is the SMILES notation for N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-methoxyethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(1,2,4-triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine;methane;N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine?

The canonical SMILES for N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-methoxyethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(1,2,4-triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine;methane;N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine is C.C.C.C.C.COCCOc1cnc2c(NCc3nnc4ccc(-c5cc(F)cc(F)c5)nn34)ccnc2c1.Cc1cc(-c2ccc3nnc(CNc4ccnc5cc(OCC(F)(F)F)cnc45)n3n2)sn1.Fc1cc(F)cc(-c2ccc3nnc(CNc4ccnc5cc(OCC(F)(F)F)cnc45)n3n2)c1.Fc1cc(F)cc(-c2ccc3nnc(CNc4ccnc5cc(OCCN6CCCC6)cnc45)n3n2)c1.Fc1cc(F)cc(-c2ccc3nnc(CNc4ccnc5cc(OCCn6cncn6)cnc45)n3n2)c1.

What is the InChIKey of N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-methoxyethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(1,2,4-triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine;methane;N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine?

The InChIKey is RETXUGRHRWJPJI-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H24F2N8O.C24H18F2N10O.C23H19F2N7O2.C22H14F5N7O.C20H15F3N8OS.5CH4/c27-18-11-17(12-19(28)13-18)21-3-4-24-32-33-25(36(24)34-21)16-30-22-5-6-29-23-14-20(15-31-26(22)23)37-10-9-35-7-1-2-8-35;25-16-7-15(8-17(26)9-16)19-1-2-22-32-33-23(36(22)34-19)12-29-20-3-4-28-21-10-18(11-30-24(20)21)37-6-5-35-14-27-13-31-35;1-33-6-7-34-17-11-20-23(28-12-17)19(4-5-26-20)27-13-22-30-29-21-3-2-18(31-32(21)22)14-8-15(24)10-16(25)9-14;23-13-5-12(6-14(24)7-13)16-1-2-19-31-32-20(34(19)33-16)10-29-17-3-4-28-18-8-15(9-30-21(17)18)35-11-22(25,26)27;1-11-6-16(33-30-11)13-2-3-17-27-28-18(31(17)29-13)9-25-14-4-5-24-15-7-12(8-26-19(14)15)32-10-20(21,22)23;;;;;/h3-6,11-15H,1-2,7-10,16H2,(H,29,30);1-4,7-11,13-14H,5-6,12H2,(H,28,29);2-5,8-12H,6-7,13H2,1H3,(H,26,27);1-9H,10-11H2,(H,28,29);2-8H,9-10H2,1H3,(H,24,25);5*1H4.

What are the key properties of N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-methoxyethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(1,2,4-triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine;methane;N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine?

N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-methoxyethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(1,2,4-triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine;methane;N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine has a molecular weight of 2506.51 g/mol, XLogP of 22.84, 36 rotatable bonds, 5 hydrogen bond donors, and 47 hydrogen bond acceptors.

Where does this data come from?

All data for N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-methoxyethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(1,2,4-triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine;methane;N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-amine is sourced from PubChem (CID 160605176), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).